Antiviral activity of WIN 54954 in coxsackievirus B2 carrier state infected human myocardial fibroblasts. (Q42544587)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497072%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Antiviral activity of WIN 54954 in coxsackievirus B2 carrier state infected human myocardial fibroblasts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497072%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497072%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Isabella M Grumbach

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497072%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

U Pfetzing

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497072%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

G Müller

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497072%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497072%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497072%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497072%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497072%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

47-56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497072%20AND%20SRC:MED&resulttype=core&format=json

Viral Myocarditis and its Sequelae

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Detection of enteroviral RNA by polymerase chain reaction in endomyocardial tissue of patients with chronic cardiac diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Inhibitors of viral uncoating

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Myocardial enterovirus infection with left ventricular dysfunction: a benign disease compared with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Antiviral treatment with WIN 54 954 reduces mortality in murine coxsackievirus B3 myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Synergistic interaction of interferon-beta and interferon-gamma in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Enterovirus-induced myocarditis: Hemodynamic deterioration with immunosuppressive therapy and successful application of interferon-α

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Cultured human myocardial fibroblasts of pediatric origin: natural human interferon-alpha is more effective than recombinant interferon-alpha 2a in carrier-state coxsackievirus B3 replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Recombinant Interferons beta and gamma have a higher antiviral activity than interferon-alpha in coxsackievirus B3-infected carrier state cultures of human myocardial fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Enterovirus heart disease of adults: a persistent, limited organ infection in the presence of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Clearance of a persistent human enterovirus infection of the mouse central nervous system by the antiviral agent disoxaril.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Nested PCR for specific detection and rapid identification of human picornaviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

1 reference

7 January 2021

Nucleotide sequencing of PCR products shows the presence of Coxsackie-B3 virus in endomyocardial biopsies from patients with myocarditis or dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Genomic detection of enteroviruses in the myocardium--studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Coxsackie B virus infections in new zealand patients with cardiac and non-cardiac diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Isolation of a Coxsackie virus group B, type 5, from the heart of a fatal case of myocarditis in an adult

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Fatal myocarditis associated with ECHO virus, type 22, infection in a child with apparent immunological deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Giant cell myocarditis due to coxsackie B2 virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

The structure of coxsackievirus B3 at 3.5 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Molecular detection and serotypic analysis of enterovirus RNA in archival specimens from patients with acute myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Complete atrioventricular block associated with regional myocardial scarring in a patient with Coxsackie B2 myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Detection of enteroviral ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Treatment of Coxsackievirus A9 myocarditis in mice with WIN 54954

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2897%2900056-9

7 January 2021

10.1016/S0166-3542(97)00056-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9497072%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference